Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Acoustofluidic platform for in-channel immunoassays

Autor: Achilefu, Samuel, Raghavachari, Ramesh, Binkley, Michael M., Cui, Mingyang, Yantis, Jennifer, Keeler, Shamus P., Gerovac, Benjamin J., Byers, Derek E., Holtzman, Michael J., Meacham, J. Mark

Publikováno v: Proceedings of SPIE; May 2019, Vol. 10893 Issue: 1 p1089304-1089304-7

A first-in-kind MAPK13 inhibitor that can correct stem cell reprogramming and post-injury disease.

Autor: Zhang Y; Pulmonary and Critical Care Medicine, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110., Wu K; Pulmonary and Critical Care Medicine, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110., Mao D; Pulmonary and Critical Care Medicine, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110., Iberg CA; Pulmonary and Critical Care Medicine, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110., Yin-Declue H; Pulmonary and Critical Care Medicine, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110., Sun K; Pulmonary and Critical Care Medicine, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110., Wikfors HA; Pulmonary and Critical Care Medicine, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110., Keeler SP; Pulmonary and Critical Care Medicine, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110., Li M; Pulmonary and Critical Care Medicine, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110., Young D; Pulmonary and Critical Care Medicine, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110., Yantis J; Pulmonary and Critical Care Medicine, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110., Crouch EC; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110., Chartock JR; Pulmonary and Critical Care Medicine, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110., Han Z; Pulmonary and Critical Care Medicine, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110., Byers DE; Pulmonary and Critical Care Medicine, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110., Brody SL; Pulmonary and Critical Care Medicine, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110., Romero AG; Pulmonary and Critical Care Medicine, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110., Holtzman MJ; Pulmonary and Critical Care Medicine, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110.; Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, MO 63110.; NuPeak Therapeutics Inc., St. Louis, MO 63105.

Publikováno v: BioRxiv : the preprint server for biology [bioRxiv] 2024 Aug 22. Date of Electronic Publication: 2024 Aug 22.

A potent MAPK13-14 inhibitor prevents airway inflammation and mucus production.

Autor: Keeler SP; Pulmonary and Critical Care Medicine, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110., Wu K; Pulmonary and Critical Care Medicine, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110., Zhang Y; Pulmonary and Critical Care Medicine, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110., Mao D; Pulmonary and Critical Care Medicine, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110., Li M; Pulmonary and Critical Care Medicine, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110., Iberg CA; Pulmonary and Critical Care Medicine, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110., Austin SR; NuPeak Therapeutics Inc., St. Louis, MO 63105., Glaser SA; Pulmonary and Critical Care Medicine, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110., Yantis J; Pulmonary and Critical Care Medicine, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110., Podgorny S; Pulmonary and Critical Care Medicine, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110., Brody SL; Pulmonary and Critical Care Medicine, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110., Chartock JR; Pulmonary and Critical Care Medicine, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110., Han Z; Pulmonary and Critical Care Medicine, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110., Byers DE; Pulmonary and Critical Care Medicine, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110., Romero AG; Pulmonary and Critical Care Medicine, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110., Holtzman MJ; Pulmonary and Critical Care Medicine, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110.; Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, MO 63110.; NuPeak Therapeutics Inc., St. Louis, MO 63105.

Publikováno v: BioRxiv : the preprint server for biology [bioRxiv] 2023 Oct 04. Date of Electronic Publication: 2023 Oct 04.